NOS3 and myocardial ischemia: Despite these multiple evidences, there are not available studies in current patient populations able to clarify whether genetically determined eNOS abnormalities and cardiometabolic risk determinants have an independent or synergistic role in CAD and myocardial ischemia manifestations.